Sign in Subscribe
Biochemistry

Breakthrough in Cancer Gene Therapy: Researchers Develop Innovative Delivery System

Strategic Insights

— 1 min read

Researchers at Yale University School of Medicine have made significant progress in cancer gene therapy by developing a novel delivery system for triplex-forming oligonucleotides (TFOs). The study, published in Molecular Therapy - Nucleic Acids, utilized a lupus-derived anti-DNA monoclonal antibody, 3E10, to target and deliver TFOs into the nucleus of cancer cells. This approach showed promising results in both HER2-positive breast cancer and other cancer models.

Key Takeaways:

  • Researchers at Yale University School of Medicine have developed a novel delivery system for triplex-forming oligonucleotides (TFOs) using a lupus-derived anti-DNA monoclonal antibody, 3E10.
  • The 3E10 antibody effectively transports TFOs into the nucleus of cancer cells, enhancing their bioavailability.
  • The study demonstrated superior binding and delivery efficiency of the D31N mutant of 3E10 in HER2-positive breast cancer models.
  • This research provides a promising platform for TFO-based precision cancer therapies, leveraging the tumor-targeting properties of 3E10.
  • Nicole M. Garcia Tubens, Anthony Minnah, Adam Krysztofiak, Yanfeng Liu, Peter M. Glazer, and Faye A. Rogers were involved in the research study.
  • The study was published in Molecular Therapy - Nucleic Acids, a peer-reviewed journal that publishes research on nucleic acid-based therapies.

Statistics:

  • The study utilized a lupus-derived anti-DNA monoclonal antibody, 3E10, as a delivery system for TFOs.
  • The D31N mutant of 3E10 demonstrated superior binding and delivery efficiency in both HER2-positive breast cancer models and other cancer models.
  • The research provides a promising platform for precision cancer therapies, with potential applications in various cancer models.

Sources:

  • Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers. Molecular Therapy - Nucleic Acids, 2025;36(4):102720.
  • Molecular Therapy - Nucleic Acids can be contacted at: Cell Press, 50 Hampshire St, Floor 5, Cambridge, MA 02139, USA.
  • Yale University School of Medicine's contact information is: Dept. of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510, United States.

Read more